Guided Therapeutics (GTHP) Amortizatization of Intangibles (2015 - 2022)
Guided Therapeutics (GTHP) posted Amortizatization of Intangibles of $50000.0 for Q3 2022, up 412.5% sequentially from -$16000.0 in Q2 2022, and down 13.79% YoY from $58000.0 in Q3 2021.
Guided Therapeutics (GTHP) Amortizatization of Intangibles (2015 - 2022) Analysis & Trends
Guided Therapeutics has reported Amortizatization of Intangibles for 7 years, with the latest figure at $50000.0 in Q3 2022.
- Quarterly Amortizatization of Intangibles fell 13.79% year-over-year to $50000.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was -$8000.0 (up 33.33% YoY) and the FY2021 annual result came in at $8000.0, changed N/A from the prior year.
- Amortizatization of Intangibles climbed to $50000.0 in Q3 2022 per GTHP's latest filing, from -$16000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $58000.0 in Q3 2021 and troughed at -$78000.0 in Q4 2020.
- A 4-year average of $10714.3 and a median of $19000.0 in 2019 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2020 and 2021: Amortizatization of Intangibles slumped 510.53% in 2020, then soared 132.0% in 2021.
- Over 4 years, Amortizatization of Intangibles stood at $19000.0 in 2019, then plunged by 510.53% to -$78000.0 in 2020, then increased by 25.64% to -$58000.0 in 2021, then soared by 186.21% to $50000.0 in 2022.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $50000.0, -$16000.0, and $16000.0 for Q3 2022, Q2 2022, and Q1 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | 24,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 50,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Jun 30, 2022 | -16,000.00 |
| Jun 30, 2022 | -16,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | -58,000.00 |
| Dec 31, 2021 | -58,000.00 |
| Sep 30, 2021 | 58,000.00 |
| Sep 30, 2021 | 58,000.00 |
| Jun 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 8,000.00 |
| Dec 31, 2020 | -78,000.00 |
| Dec 31, 2020 | -78,000.00 |
| Sep 30, 2020 | 25,000.00 |
| Sep 30, 2020 | 25,000.00 |
| Jun 30, 2020 | 34,000.00 |
| Jun 30, 2020 | 34,000.00 |
| Mar 31, 2020 | 19,000.00 |
| Mar 31, 2020 | 19,000.00 |